International Journal of Biological Macromolecules 2005-07-01

Study of graft copolymerization of N-maleamic acid-chitosan and butyl acrylate by gamma-ray irradiation.

Meifang Huang, Xiaofeng Shen, Yuan Sheng, Yue'e Fang

Index: Int. J. Biol. Macromol. 36(1-2) , 98-102, (2005)

Full Text: HTML

Abstract

N-maleamic acid-chitosan was synthesized and characterized by Fourier transform infrared spectra analysis (FT-IR) and 1H NMR. The graft copolymerization of N-maleamic acid-chitosan and butyl acrylate (BA) in acetic acid aqueous solution was investigated, using the gamma-ray of 60Co gamma-irradiation method. DSC (differential scanning calorimetry) trace of N-maleamic acid-chitosan-g-PBA has a glass-transition temperature (Tg) at -42 degrees C. The thermal stabilities of the graft copolymer were studied by the thermal gravimetric analysis (TGA). The effect of synthesis variables in the graft copolymerization have been discussed in the light of grafting efficiency, grafting percentage, and homopolymer percentage. Increasing grafting percentage was observed when the monomer concentration and total dose were increased or when the reaction temperature was decreased.


Related Compounds

Related Articles:

Hapten synthesis and development of a competitive indirect enzyme-linked immunosorbent assay for acrylamide in food samples.

2014-07-23

[J. Agric. Food Chem. 62(29) , 7078-84, (2014)]

N-Phenyl and N-phenylalkyl-maleimides acting against Candida spp.: time-to-kill, stability, interaction with maleamic acids.

2008-01-01

[Bioorg. Med. Chem. 16 , 560-8, (2008)]

Selective adsorption of D- and L-phenylalanine on molecularly-imprinted polymerized organogels formed using polymerizable gelator N-octadecyl maleamic acid.

2008-12-01

[J. Sep. Sci. 31(21) , 3782-7, (2008)]

Structure and catalytic mechanism of nicotinate (vitamin B3) degradative enzyme maleamate amidohydrolase from Bordetella bronchiseptica RB50.

2012-01-10

[Biochemistry 51(1) , 545-54, (2012)]

PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver.

2010-08-01

[J. Pharm. Pharmacol. 62(8) , 985-94, (2010)]

More Articles...